NONA
IDXX icon

Ninety One North America’s Idexx Laboratories IDXX Stock Holding History

Ninety One North America’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-12,036
Closed -$5.86M – 76
2024
Q2 		$5.86M Sell
12,036
-782
-6% -$393K 0.3% 55
2024
Q1 		$6.92M Buy
12,818
+926
+8% +$506K 0.34% 49
2023
Q4 		$6.6M Buy
11,892
+5,063
+74% +$2.38M 0.32% 50
2023
Q3 		$2.99M Sell
6,829
-41
-0.6% -$20.4K 0.15% 63
2023
Q2 		$3.45M Buy
6,870
+152
+2% +$72.8K 0.15% 82
2023
Q1 		$3.36M Buy
6,718
+241
+4% +$115K 0.15% 77
2022
Q4 		$2.64M Buy
+6,477
New +$2.51M 0.13% 78

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Ninety One North America's IDXX Position: Q3 2024 in Review

Ninety One North America sold out of Idexx Laboratories (IDXX) in Q3 2024, closing a stake of 12,036 shares — an estimated $5.86M sold.

Ninety One North America first reported a position in IDXX in Q4 2022 and held it in 7 quarters. The position peaked at $6.92M in Q1 2024. 1,116 funds tracked by Wall St. Rank hold IDXX as of Q3 2024.

  • Ninety One North America reported no remaining Idexx Laboratories position as of Q3 2024 after selling out during the quarter.
  • Ninety One North America sold 12,036 Idexx Laboratories shares in Q3 2024, an estimated $5.86M.
  • Ninety One North America first reported a position in Idexx Laboratories in Q4 2022 and held it in 7 quarters.
  • Ninety One North America's Idexx Laboratories position peaked at $6.92M in Q1 2024.
  • 1,116 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2024.

Based on Ninety One North America's 13F filing for Q3 2024, filed 12 Nov 2024.